Form 4: Kenvue Director Sarah Hofstetter Receives Equity Grant Through Deferred Share Units

Kenvue Inc. Director Sarah Hofstetter was granted 7,659 Deferred Share Units as part of her compensation, aligning her interests with shareholders.

Summary

• Sarah Hofstetter, a Director of Kenvue Inc. (KVUE), acquired 7,659 Deferred Share Units (DSUs) on May 22, 2025.
• These DSUs were granted under Kenvue's Amended and Restated Deferred Fee Plan for Directors.
• Each DSU represents the right to receive one share of Kenvue's common stock upon the termination of Ms. Hofstetter's directorship.
• The reported price of these DSUs was $23.5 per unit.
• Following this transaction, Ms. Hofstetter beneficially owns a total of 9,656 Deferred Share Units.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates a routine compensation grant that aligns director interests with shareholders, without any negative implications or unexpected events.

Positives

• The grant of Deferred Share Units to a director aligns their financial interests with those of the company's shareholders, encouraging long-term value creation.
• The transaction is part of a pre-existing, disclosed compensation plan (Amended and Restated Deferred Fee Plan for Directors), indicating a structured approach to executive and director remuneration.

Future Outlook

The document primarily reports a past transaction and does not provide specific forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the settlement of DSUs upon termination of directorship.

Industry Context

The grant of equity-based compensation, such as Deferred Share Units, to non-employee directors is a common practice across publicly traded companies in various industries, including consumer health, to align director incentives with long-term shareholder value.

Comparison to Industry Standards

• The use of Deferred Share Units (DSUs) as a component of director compensation is a standard practice, comparable to similar plans at companies like Procter & Gamble (PG) or Johnson & Johnson (JNJ), from which Kenvue was spun off.
• The structure, where DSUs settle in common stock upon termination of directorship, is a typical mechanism designed to defer income and encourage long-term commitment.

Corporate Governance

Related Party Transactions

• The grant of 7,659 Deferred Share Units to Sarah Hofstetter, a Director of Kenvue Inc., constitutes a transaction with a related party (an insider) as part of her compensation under the company's Deferred Fee Plan for Directors.

Stakeholder Impact

• Shareholders: The grant of equity to a director helps align the director's long-term interests with those of the shareholders, potentially leading to more shareholder-centric decision-making.
• Employees: No direct impact on employees is indicated by this specific filing.

Next Steps

• The Deferred Share Units granted to Sarah Hofstetter will be settled in shares of Kenvue's common stock upon the termination of her directorship.

Key Dates

Keywords

Kenvue, KVUE, Form 4, Insider Transaction, Director Compensation, Equity Grant, Deferred Share Units, Beneficial Ownership